USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Next Generation Sequencing Market By Application (Oncology, Clinical Investigation, Reproductive Health, Metagenomics, Epidemiology & Drug Development, Consumer Genomics, Agrigenomics & Forensics and HLA Typing/Immune System Monitoring) By Technology(Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing)By End Use(Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other users): Global Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026

Industry Insights

[195+ Pages Report] According to the report published by Facts and Factors, the global Next Generation Sequencing market was valued at approximately USD 4,349.2 Million in 2019, and is expected to generate revenue of around USD 12,624.3 Million by end of 2026, growing at a CAGR of around 16.4% between 2020 and 2026.

logoMarket Overview              

Next-generation sequencing technologies make it possible to sequence RNA and DNA in a reliable and cost-effective manner. These technologies are widely used in functional genomics to test DNA and RNA samples. The demand for next-generation sequencing will grow across all clinical applications. Next-generation sequencing (NGS) refers to large-scale DNA sequencing methods that assist in genome exploration. The term "next-generation sequencing," also known as "high-throughput sequencing," refers to a variety of modern sequencing technologies.

logoIndustry Growth Factors

Because of technical advances in NGS, an increase in NGS applications, and an increase in alliances and collaborations, the global next generation sequencing market is growing. Furthermore, the increase in genome mapping programs propels the global next generation sequencing market forward. However, concerns about standardization in NGS-based diagnostics, a shortage of qualified clinicians, and ethical and legal constraints are expected to stymie the market's growth. On the other hand, lucrative prospects in developing markets, as well as cloud computing as a future data management service, are expected to pay off handsomely for market participants.

logoSegmentation Analysis

The global next generation sequencing market is segregated based application, technology and end-use and regions. 

Oncology, clinical investigation, reproductive health, metagenomics, epidemiology & drug development, consumer genomics, agrigenomics & forensics and HLA typing/immune system monitoring are the application segment of global next generation sequencing market. In 2019, oncology brought in the most revenue, accounting for over 31.3% of total sales. The combination of next-generation sequencing (NGS) and bioinformatics tools has the ability to transform oncology discovery, diagnosis, and treatment. Advances in NGS technology have resulted in advancements in cancer science, signaling the start of cancer's "molecular era." The technology segment is categorized into whole genome sequencing, whole exome sequencing and targeted sequencing & resequencing. Moreover, the report is also categorized end use segment into academic research, clinical research, hospitals & clinics, pharma & biotech entities and other users

logo Regional Analysis

With a sales share of 47.85% in 2019, North America dominated the global market. The regional market is driven by the involvement of many clinical laboratories that use NGS to provide genetic testing services. In addition, main companies in North America are developing and launching new products, which is boosting business growth. For example, Quest Diagnostics launched the Automated NGS Engine in August 2020 to power AncestryHealth, Ancestry's consumer genetics offering. Genetic screening for blood disorders, bowel cancer, breast cancer, and heart disease is available via the platform.

Due to increased technological advances and funding provided by the government and private organizations, Asia-Pacific is expected to have the highest CAGR during the forecast era. Furthermore, increased investment by biotechnology and pharmaceutical companies is expected to boost consumer demand.

logo Competitive Players

Some main participants of the Next Generation Sequencing market are Genomatix GmbH, PierianDx; DNASTAR, Inc., Eurofins GATC Biotech GmbH, Illumina, QIAGEN, Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Oxford Nanopore Technologies, Perkin Elmer, Inc., Bio-Rad Laboratories, Inc. and BGI amongst others.

Covid-19

Next Generation Sequencing Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Genomatix GmbH
  • PierianDxDNASTAR Inc.
  • Eurofins GATC Biotech GmbH
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • F. Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies
  • Perkin Elmer Inc.
  • Bio-Rad Laboratories Inc.
  • BGI

Frequently Asked Questions

Strict enforcement of laws by government authorities mandating Next Generation Sequencing Market.
According to Facts and Factors research report, the global Next Generation Sequencing Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Next Generation Sequencing Market will drive regional market trends. With regional governments enforcing strict laws pertaining to drug abuse, the market for Next Generation Sequencing Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Next Generation Sequencing Market in North America over coming decade.
why choose fnf
key questions answers

Related Reports

report img

Cell and Gene Therapy Consumables Market Report 2022 – 2028

[216+ Pages Report] According to Facts and Factors, the global cell and gene therapy consumables market was worth USD 6,294.10 million in 2021 and is estimated to grow to USD 17,427.85 million by 2028, with a compound annual growth rate (CAGR) of approximately 18.50% over the forecast period. The ...

Published Date : 16-Aug-2022 | | Category : | Pages : 216 | Format : Read more

Inquiry for Buying Request Sample
report img

Biotechnology Instruments Market Report , 2021 – 2026

According to the report published by Facts and Factors, global demand for the biotechnology instruments market was estimated at approximately USD 41,006.2 Million in 2020 and is expected to generate revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% betwe...

Published Date : 18-Jan-2022 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample